Delineation of organs at risk involved in swallowing for radiotherapy treatment planning.
about
Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment.Development of a standardized method for contouring the larynx and its substructuresMulticriteria optimization enables less experienced planners to efficiently produce high quality treatment plans in head and neck cancer radiotherapyPATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer.DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancerEvaluating swallowing muscles essential for hyolaryngeal elevation by using muscle functional magnetic resonance imaging.How does radiotherapy impact swallowing function in nasopharynx and oropharynx cancer? Short-term results of a prospective study.3D Variation in delineation of head and neck organs at risk.Practical considerations in reducing swallowing dysfunction following concurrent chemoradiotherapy with intensity-modulated radiotherapy for head and neck cancer.Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review.Sparing functional anatomical structures during intensity-modulated radiotherapy: an old problem, a new solution.The management of head and neck tumors with high technology radiation therapy.A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy : A systematic review by the Italian Head and Neck Radiotherapy Study Group.Toward optimal organ at risk sparing in complex volumetric modulated arc therapy: an exponential trade-off with target volume dose homogeneity.Radiation-induced acute dysphagia : Prospective observational study on 42 head and neck cancer patients.Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients.Prophylactic Swallowing Exercises in Head and Neck Cancer Radiotherapy.Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: is there a place for critical swallowing structures dose sparing?Evaluation of an automatic segmentation algorithm for definition of head and neck organs at risk.Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.Dose-dependent deterioration of swallowing function after induction chemotherapy and definitive chemoradiotherapy for laryngopharyngeal cancer.Effectiveness of tapentadol prolonged release for the management of painful mucositis in head and neck cancers during intensity modulated radiation therapy.Delineation of the larynx as organ at risk in radiotherapy: a contouring course within "Rete Oncologica Piemonte-Valle d'Aosta" network to reduce inter- and intraobserver variability.Dysphagia after definitive radiotherapy for head and neck cancer. Correlation of dose-volume parameters of the pharyngeal constrictor muscles.Delineating brachial plexus, cochlea, pharyngeal constrictor muscles and optic chiasm in head and neck radiotherapy: a CT-based model atlas.Accuracy of software-assisted contour propagation from planning CT to cone beam CT in head and neck radiotherapy.Detailed evaluation of an automated approach to interactive optimization for volumetric modulated arc therapy plans.Radiation-induced late dysphagia after intensity-modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume effect analysis
P2860
Q34568221-9D4A475E-D24D-4BBE-994B-12E3A2A37F1EQ34706759-2432E728-08A2-4419-A33C-728437B44373Q35427311-B1F5D74F-D927-4F40-92E7-2B9AEF7EC20BQ35756867-C90E95DE-6808-4BCE-B775-F02144EB89D6Q36156806-04B40051-A202-451C-8849-00668B15AA93Q36586285-8B1F094C-BB67-438F-A259-1816572B2F93Q37140870-4D4E3C5F-BD5A-447F-A26D-9EFBD30437D7Q37993227-8FEFA94E-DE39-4E2D-AA15-3044756EA500Q38090999-4D41BE83-A6C2-4AB6-A5F1-9C4348BC5A59Q38119441-BCE79254-8F92-46DB-B2AC-5FAA2DDF335EQ38132448-908D390B-7522-4ED7-9C08-370D5E14AF69Q38411314-053A2377-66AF-46C2-B748-E52BAD10D018Q38724864-B73C57BB-7AEA-4FA2-BD8E-F71EE0903E3FQ39254486-E2260CC1-7B95-41BA-A71E-87CF810B376FQ40051688-5DF8A64C-1ED3-4223-9FD3-5EBD5FB75D50Q41244179-CB650ABF-560E-4717-98D3-FB3459F1CA9BQ41410758-605D6C5E-5FE8-4990-BAD2-D66C2D7BD969Q41757990-6E652750-2AD3-4507-BCF6-1B9B23983EE7Q41891737-3B2A3CE8-F2EA-4779-980A-AB29C05E3192Q42368040-A606AE32-137A-445C-9316-9ECE75A95A00Q45767378-04E37B9E-A5BC-45DB-BF1C-91FBEDAB80ECQ47834525-FB2FB02D-49EB-40FB-9462-A8B21D867B83Q48157099-8AD42185-51BB-41A6-8ABA-09B9D736DAAEQ48317653-33B863CF-6B11-4468-B327-A8DA7A0E89AFQ48621248-E4A57F32-2250-4F35-B5D5-34206C16068CQ50592113-06F2A63D-A5D7-4719-A7C8-5CE66B99C6D4Q50864932-98467C01-27DA-4776-B38E-75BB79BDB116Q58608754-9B7B7738-8B49-48EB-9F5E-179BEFE0ECDE
P2860
Delineation of organs at risk involved in swallowing for radiotherapy treatment planning.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Delineation of organs at risk involved in swallowing for radiotherapy treatment planning.
@en
Delineation of organs at risk involved in swallowing for radiotherapy treatment planning.
@nl
type
label
Delineation of organs at risk involved in swallowing for radiotherapy treatment planning.
@en
Delineation of organs at risk involved in swallowing for radiotherapy treatment planning.
@nl
prefLabel
Delineation of organs at risk involved in swallowing for radiotherapy treatment planning.
@en
Delineation of organs at risk involved in swallowing for radiotherapy treatment planning.
@nl
P2093
P1476
Delineation of organs at risk involved in swallowing for radiotherapy treatment planning.
@en
P2093
Hendrik P Bijl
Henriëtte E Westerlaan
Johannes A Langendijk
Miranda E M C Christianen
Tara A van de Water
P304
P356
10.1016/J.RADONC.2011.05.015
P577
2011-06-12T00:00:00Z